{% extends "layout.html" %}
  
{% block title %}Parts{% endblock %}
{% block lead %}This page contains information about the parts created by the team.{% endblock %}

{% block extraStyles %}

<link href="{{ url_for('static', filename = 'css/parts.css') }}" rel="stylesheet">

{% endblock %}

{% block page_content %}
<div class="standard-header banner-v2 curvy-divider">
  <h1> Parts </h1>
  <div class="simple-wave-divider">
    <svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1200 120" preserveAspectRatio="none">
        <path d="M985.66,92.83C906.67,72,823.78,31,743.84,14.19c-82.26-17.34-168.06-16.33-250.45.39-57.84,11.73-114,31.07-172,41.86A600.21,600.21,0,0,1,0,27.35V120H1200V95.8C1132.19,118.92,1055.71,111.31,985.66,92.83Z" class="shape-fill"></path>
    </svg>
  </div>
</div>

<div class="d-flex flex-column align-items-center justify-content-center">
  <div class="body-container narrow">
    <div class="narrow-content d-flex flex-row align-items-center justify-content-center flex-wrap flex-lg-nowrap">
      <div class="container" id="head1">
        <h2>Parts Catalog</h2>
        <p>All of the parts created and documented over the course of the project are on this page. Below is a table of parts added to the registry, along with a plasmid viewer to help visualize all of our parts. All parts seen here have been engineered by the Virginia iGEM Team using components of publicly-available antibody sequences.</p>
      </div>
      <div class="img-wrapper plasmid-viewer">
        <img src="https://static.igem.wiki/teams/4477/wiki/images/plasmidwindow.svg" alt="plasmid window">
      </div>
    </div>
  </div>

  <div class="body-container d-flex align-items-center justify-content-center">
    <div class="body-section top-page">
      <div class="text-wrapper">
        <h2>Parts Table</h2>
        <p>We added a total of ten basic parts (BBa_K4477001-BBa_K4477010) and four composite parts (BBa_K4477011-BBa_K4477014) to the registry. </p>
      </div>
      
      <div class="text-wrapper">
        <h4>Basic Parts</h4>
      </div>
      <div class="tbl-wrapper">
        <table class="table table-striped">
          <thead>
            <tr>
              <th scope="col">Part Number</th>
              <th scope="col">Type</th>
              <th scope="col">Description</th>
              <th scope="col">Designers</th>
              <th scope="col">Length</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <th scope="row"><a href="http://parts.igem.org/Part:BBa_K4477001">BBa_K4477001</a></th>
              <td>Coding, Anti-oxLDL IgG Light Chain</td>
              <td>This sequence codes for the light chain of an anti-apoB(MDA) immunoglobulin G (IgG), an Orticumab-biosimilar antibody</td>
              <td>Miranda Khoury</td>
              <td>654 bp</td>
            </tr>
            <tr>
              <th scope="row">BBa_K4477002</th>
              <td>Coding, Anti-oxLDL IgG Heavy Chain</td>
              <td>This sequence codes for the heavy chain of an anti-apoB(MDA) immunoglobulin G (IgG), an Orticumab-biosimilar antibody</td>
              <td>Miranda Khoury</td>
              <td></td>
            </tr>
            <tr>
              <th scope="row">BBa_K4477003</th>
              <td>Coding, IK-17 Anti-oxLDL scFv Antibody</td>
              <td>This sequence codes for a short chain variable fragment (scFv) derived from the anti-oxLDL IK17 antibody. Specifically, this scFv targets a protein structure called MDA-modified apo-B (apoB(MDA)) that is part of an oxLDL molecule.</td>
              <td>Miranda Khoury</td>
              <td>795 bp</td>
            </tr>
  
            <tr>
              <th scope="row">BBa_K4477004</th>
              <td>Coding, McPC603 Anti-oxLDL scFv Antibody</td>
              <td>This sequence codes for a short chain variable fragment (scFv) derived from the anti-oxLDL McPC603 antibody, which targets oxidized phosphocholine on oxLDL.</td>
              <td>Miranda Khoury</td>
              <td>798 bp</td>
            </tr>
  
            <tr>
              <th scope="row">BBa_K4477005</th>
              <td>Coding, Anti-mouse Camelid VHH Antibody</td>
              <td>This sequence codes for a VHH region antibody fragment, also referred to as an nanobody. It binds to the constant chain region of mouse-derived IgGs.</td>
              <td>Miranda Khoury</td>
              <td>408 bp</td>
            </tr>
  
            <tr>
              <th scope="row">BBa_K4477006</th>
              <td>RBS, Orticumab-Biosimilar Light Chain expression</td>
              <td>RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of an IgG light chain for an anti-oxLDL antibody we designed (BBa_K4477001).</td>
              <td>Miranda Khoury</td>
              <td>27 bp</td>
            </tr>
  
            <tr>
              <th scope="row">BBa_K4477007</th>
              <td>RBS, Orticumab-Biosimilar Heavy Chain expression</td>
              <td>RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of the heavy chain of our Orticumab biosimilar (anti-oxLDL) antibody (BBa_K4477002).</td>
              <td>Miranda Khoury</td>
              <td>26 bp</td>
            </tr>
  
            <tr>
              <th scope="row">BBa_K4477008</th>
              <td>RBS, IK-17 scFv expression </td>
              <td>RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of one of our designed IgG heavy chains (BBa_K4477003).</td>
              <td>Miranda Khoury</td>
              <td>30 bp</td>
            </tr>
  
            <tr>
              <th scope="row">BBa_K4477009</th>
              <td>RBS, McPC603 scFv expression</td>
              <td>RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of one of our designed scFvs (BBa_K4477004).</td>
              <td>Miranda Khoury</td>
              <td>31 bp</td>
            </tr>
  
            <tr>
              <th scope="row">BBa_K4477010</th>
              <td>RBS, VHH expression</td>
              <td>RBS that Team Virginia 2022 designed with the Salis RBS calculator for 75% relative expression of one of our designed VHH antibody fragments (BBa_K4477005).</td>
              <td>Miranda Khoury</td>
              <td>39 bp</td>
            </tr>
          </tbody>
        </table>
      </div>

      <div class="text-wrapper">
        <h4>Composite Parts</h4>
      </div>
      <div class="tbl-wrapper">
        <table class="table table-striped">
          <thead>
            <tr>
              <th scope="col">Part Number</th>
              <th scope="col">Type</th>
              <th scope="col">Description</th>
              <th scope="col">Designers</th>
              <th scope="col">Length</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <th scope="row"><a href="http://parts.igem.org/Part:BBa_K4477011">BBa_K4477011</a></th>
              <td>Composite, Complete Orticumab-biosimilar Anti-human oxLDL</td>
              <td>This sequence codes for a full IgG anti-apoB(MDA). It is derived partially from Orticumab, a human antibody that is currently in development.</td>
              <td>Miranda Khoury</td>
              <td>2186 bp</td>
            </tr>
            <tr>
              <th scope="row">BBa_K4477012</th>
              <td>Coding, Anti-oxLDL IgG Heavy Chain</td>
              <td>This sequence codes for the heavy chain of an anti-apoB(MDA) immunoglobulin G (IgG), an Orticumab-biosimilar antibody</td>
              <td>Miranda Khoury</td>
              <td></td>
            </tr>
            <tr>
              <th scope="row">BBa_K4477013</th>
              <td>Coding, IK-17 Anti-oxLDL scFv Antibody</td>
              <td>This sequence codes for a short chain variable fragment (scFv) derived from the anti-oxLDL IK17 antibody. Specifically, this scFv targets a protein structure called MDA-modified apo-B (apoB(MDA)) that is part of an oxLDL molecule.</td>
              <td>Miranda Khoury</td>
              <td>795 bp</td>
            </tr>
  
            <tr>
              <th scope="row">BBa_K4477014</th>
              <td>Coding, McPC603 Anti-oxLDL scFv Antibody</td>
              <td>This sequence codes for a short chain variable fragment (scFv) derived from the anti-oxLDL McPC603 antibody, which targets oxidized phosphocholine on oxLDL.</td>
              <td>Miranda Khoury</td>
              <td>798 bp</td>
            </tr>
          </tbody>
        </table>

      </div>

    </div>

  </div>
  




  <div class="container">
    <div class="body-section">
      <div class="container d-flex flex-column">
        <h4>Antibody 1 [Orticumab Biosimilar] Complete Device (4892 bp)</h4>

        <div class="hidden" id="root">
          <script src="{{ url_for('static', filename='seqviz/seqviz.min.js') }}"></script>
    
          <script>
              var viewer = seqviz.Viewer("root", {
              name: "Antibody 1 Plasmid",
              seq: "TAAGGATGATTTCTGGAATTCGCGGCCGCTTCTAGAGCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACATACTAGAGAAAGAGGAGAAATACTAGATGGCTTCCTCCGAAGACGTTATCAAAGAGTTCATGCGTTTCAAAGTTCGTATGGAAGGTTCCGTTAACGGTCACGAGTTCGAAATCGAAGGTGAAGGTGAAGGTCGTCCGTACGAAGGTACCCAGACCGCTAAACTGAAAGTTACCAAAGGTGGTCCGCTGCCGTTCGCTTGGGACATCCTGTCCCCGCAGTTCCAGTACGGTTCCAAAGCTTACGTTAAACACCCGGCTGACATCCCGGACTACCTGAAACTGTCCTTCCCGGAAGGTTTCAAATGGGAACGTGTTATGAACTTCGAAGACGGTGGTGTTGTTACCGTTACCCAGGACTCCTCCCTGCAAGACGGTGAGTTCATCTACAAAGTTAAACTGCGTGGTACCAACTTCCCGTCCGACGGTCCGGTTATGCAGAAAAAAACCATGGGTTGGGAAGCTTCCACCGAACGTATGTACCCGGAAGACGGTGCTCTGAAAGGTGAAATCAAAATGCGTCTGAAACTGAAAGACGGTGGTCACTACGACGCTGAAGTTAAAACCACCTACATGGCTAAAAAACCGGTTCAGCTGCCGGGTGCTTACAAAACCGACATCAAACTGGACATCACCTCCCACAACGAAGACTACACCATCGTTGAACAGTACGAACGTGCTGAAGGTCGTCACTCCACCGGTGCTTAATAACGCTGATAGTGCTAGTGTAGATCGCTACTAGAGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCTACTAGAGTCACACTGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATATACTAGTAGCGGCCGCTGCAGGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATCTCGAGTCCCGTCAAGTCAGCGTAATGCTCTGCCAGTGTTACAACCAATTAACCAATTCTGATTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCGATACCATATTTTTGAAAAAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCGACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCATGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGCTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAGCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGAGACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACACTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGGGGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCATAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTATCGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTGGAGCAAGACGTTTCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGATGATATATTTTTATCTTGTGCAATGTAACATCAGAGATTTTGAGACACAACGTGGCTTTGTTGAATAAATCGAACTTTTGCTGAGTTGAAGGATCAGATCACGCATCTTCCCGACAACGCAGACCGTTCCGTGGCAAAGCAAAAGTTCAAAATCACCAACTGGTCCACCTACAACAAAGCTCTCATCAACCGTGGCTCCCTCACTTTCTGGCTGGATGATGGGGCGATTCAGGCCTGGTATGAGTCAGCAACACCTTCTTCACGAGGCAGACCTCAGCGCTAGCGGAGTGTATACTGGCTTACTATGTTGGCACTGATGAGGGTGTCAGTGAAGTGCTTCATGTGGCAGGAGAAAAAAGGCTGCACCGGTGCGTCAGCAGAATATGTGATACAGGATATATTCCGCTTCCTCGCTCACTGACTCGCTACGCTCGGTCGTTCGACTGCGGCGAGCGGAAATGGCTTACGAACGGGGCGGAGATTTCCTGGAAGATGCCAGGAAGATACTTAACAGGGAAGTGAGAGGGCCGCGGCAAAGCCGTTTTTCCATAGGCTCCGCCCCCTGACAAGCATCACGAAATCTGACGCTCAAATCAGTGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGCGGCTCCCTCGTGCGCTCTCCTGTTCCTGCCTTTCGGTTTACCGGTGTCATTCCGCTGTTATGGCCGCGTTTGTCTCATTCCACGCCTGACACTCAGTTCCGGGTAGGCAGTTCGCTCCAAGCTGGACTGTATGCACGAACCCCCCGTTCAGTCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGAAAGACATGCAAAAGCACCACTGGCAGCAGCCACTGGTAATTGATTTAGAGGAGTTAGTCTTGAAGTCATGCGCCGGTTAAGGCTAAACTGAAAGGACAAGTTTTGGTGACTGCGCTCCTCCAAGCCAGTTACCTCGGTTCAAAGAGTTGGTAGCTCAGAGAACCTTCAAAAAACCGCCCTGCAAGGCGGTTTTTTCGTTTTCAGAGCAAGAGATTACGCGCAGACCAAAACGATCTCAAGAAGATCATCTTATTAAGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTCCATGGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCAGAATTTCAGATAAAAAAAATCCTTAGCTTTCGC",
              style: { height: "80vh", width: "80vw" },
  
              annotations:
                  [{ start: 311, end: 988, name: "mRFP1", color: "red", direction: 1 }, // [0, 22)
              ],
              })
              viewer.render();
              viewer.renderToString();
  
          </script>
        </div>
      </div>
    </div>
  </div>
</div>

{% endblock %}
